The World Heart Federation global study on COVID-19 and cardiovascular disease

Detalhes bibliográficos
Autor(a) principal: Sliwa, Karen
Data de Publicação: 2021
Outros Autores: Singh, Kavita, Raspail, Lana, Ojji, Dike, Lam, Carolyn S.P., Thienemann, Friedrich, Ge, Junbo, Banerjee, Amitava, Newby, L. Kristin, Ribeiro, Antonio Luiz P., Gidding, Samuel, Pinto, Fausto J., Perel, Pablo, Prabhakaran, Dorairaj
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/47549
Resumo: © 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/
id RCAP_22b010b729a98f982e92288e9a7ba9ab
oai_identifier_str oai:repositorio.ul.pt:10451/47549
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The World Heart Federation global study on COVID-19 and cardiovascular diseaseCOVID-19RegistryCohortSurveyCoronavirusCardiovascular diseaseRheumatic heart diseaseChagas diseaseHIV© 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/Background: The emergence of novel coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an unprecedented global challenge for the healthcare community. The ability of SARS-CoV-2 to get transmitted during the asymptomatic phase, and its high infectivity have led to the rapid transmission of COVID-19 beyond geographic regions facilitated by international travel, leading to a pandemic. To guide effective control and interventions, primary data is required urgently, globally, including from low- and middle-income countries where documentation of cardiovascular manifestations and risk factors in people hospitalized with COVID-19 is limited. Objectives: This study aims to describe the cardiovascular manifestations and cardiovascular risk factors in patients hospitalized with COVID-19. Methods: We propose to conduct an observational cohort study involving 5000 patients recruited from hospitals in low-, middle- and high-income countries. Eligible adult COVID-19 patients will be recruited from the participating hospitals and followed-up until 30 days post admission. The outcomes will be reported at discharge and includes the need of ICU admission, need of ventilator, death (with cause), major adverse cardiovascular events, neurological outcomes, acute renal failure, and pulmonary outcomes. Conclusion: Given the enormous burden posed by COVID-19 and the associated severe prognostic implication of CVD involvement, this study will provide useful insights on the risk factors for severe disease, clinical presentation, and outcomes of various cardiovascular manifestations in COVID-19 patients particularly from low and middle income countries from where the data remain scant.Dr. Kavita Singh is supported by the National Institutes of Health, Fogarty International Centre, USA; Emerging Global Leader grant award number: 1 K43 TW011164. Dr. Ribeiro is supported in part by Brazilian Agencies CNPq (310679/2016-8 and 465518/2014-1), by FAPEMIG (PPM-00428-17) and CAPES (88887.507149/2020-00), Prof. Karen Sliwa acknowledges support from the SERVIER/Hippocrate Foundation. The WHF COVID-19 Global Cardiovascular Disease Study is funded by WHF and at the time of the publica-tion, also by Sanofi Pasteur and PfizerUbiquity PressRepositório da Universidade de LisboaSliwa, KarenSingh, KavitaRaspail, LanaOjji, DikeLam, Carolyn S.P.Thienemann, FriedrichGe, JunboBanerjee, AmitavaNewby, L. KristinRibeiro, Antonio Luiz P.Gidding, SamuelPinto, Fausto J.Perel, PabloPrabhakaran, Dorairaj2021-04-26T11:29:09Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/47549engGlobal Heart. 2021;16(1):222211-816010.5334/gh.9502211-8179info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:50:32Zoai:repositorio.ul.pt:10451/47549Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:59:34.100444Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The World Heart Federation global study on COVID-19 and cardiovascular disease
title The World Heart Federation global study on COVID-19 and cardiovascular disease
spellingShingle The World Heart Federation global study on COVID-19 and cardiovascular disease
Sliwa, Karen
COVID-19
Registry
Cohort
Survey
Coronavirus
Cardiovascular disease
Rheumatic heart disease
Chagas disease
HIV
title_short The World Heart Federation global study on COVID-19 and cardiovascular disease
title_full The World Heart Federation global study on COVID-19 and cardiovascular disease
title_fullStr The World Heart Federation global study on COVID-19 and cardiovascular disease
title_full_unstemmed The World Heart Federation global study on COVID-19 and cardiovascular disease
title_sort The World Heart Federation global study on COVID-19 and cardiovascular disease
author Sliwa, Karen
author_facet Sliwa, Karen
Singh, Kavita
Raspail, Lana
Ojji, Dike
Lam, Carolyn S.P.
Thienemann, Friedrich
Ge, Junbo
Banerjee, Amitava
Newby, L. Kristin
Ribeiro, Antonio Luiz P.
Gidding, Samuel
Pinto, Fausto J.
Perel, Pablo
Prabhakaran, Dorairaj
author_role author
author2 Singh, Kavita
Raspail, Lana
Ojji, Dike
Lam, Carolyn S.P.
Thienemann, Friedrich
Ge, Junbo
Banerjee, Amitava
Newby, L. Kristin
Ribeiro, Antonio Luiz P.
Gidding, Samuel
Pinto, Fausto J.
Perel, Pablo
Prabhakaran, Dorairaj
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Sliwa, Karen
Singh, Kavita
Raspail, Lana
Ojji, Dike
Lam, Carolyn S.P.
Thienemann, Friedrich
Ge, Junbo
Banerjee, Amitava
Newby, L. Kristin
Ribeiro, Antonio Luiz P.
Gidding, Samuel
Pinto, Fausto J.
Perel, Pablo
Prabhakaran, Dorairaj
dc.subject.por.fl_str_mv COVID-19
Registry
Cohort
Survey
Coronavirus
Cardiovascular disease
Rheumatic heart disease
Chagas disease
HIV
topic COVID-19
Registry
Cohort
Survey
Coronavirus
Cardiovascular disease
Rheumatic heart disease
Chagas disease
HIV
description © 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/
publishDate 2021
dc.date.none.fl_str_mv 2021-04-26T11:29:09Z
2021
2021-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/47549
url http://hdl.handle.net/10451/47549
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Global Heart. 2021;16(1):22
2211-8160
10.5334/gh.950
2211-8179
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ubiquity Press
publisher.none.fl_str_mv Ubiquity Press
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134541952057344